Investing Profile

Eric Anschutz

AngelInvestorScoutFounder

Experienced angel with biotech focus. Selective deal flow supported by quantitative evaluation system. Proven, exit-driven results over 15+ years. Bike lover.

angel.co/s/anschutz/2oq0tSan Francisco, California
Photo of Eric Anschutz

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$10K - $250K
$25K
30
CompanyStageDateRound SizeTotal Raised
Attivare Therapeutics
SeedJun 2021$1
$5.000001M
Co-investors: Maximilian Winter (Harmonix Fund)
HDT Bio
Seed RoundFeb 2021$6M
$6M
Primordial Genetics
Seed RoundFeb 2021$1
$1
SMBX
Seed RoundAug 2020$2.5M
$2.5M
Co-investors: Jordan Fliegel (Techstars)
OccamzRazor
Seed RoundMay 2019$4.5M
Seed RoundFeb 2017
$4.5M
Co-investors: Phil Libin (General Catalyst), Nate Dalton (Daybreak Partners)
MycoWorks
Venture RoundOct 2018
SeedMar 2018$1
$45.000001M
Co-investors: Arvind Gupta (Mayfield), Seth Berman (Susa Ventures), Po Bronson (SOSV)
Notable Labs
Series BSep 2017$14.8M
$35.65M
Co-investors: Charlie Pinto (Bling Capital), Ross Blankenship (Angel Kings), Kevin Mahaffey (SNR), Jim Kim (formation|8), Stefano Bernardi
Twist Bioscience
Series DMar 2017$33M
Series DJan 2016$61M
$166.1M
Co-investors: Omri Amirav Drory (NFX), Boris Nikolic (Biomatics Capital Partners), Gibb Witham (Paladin Capital), rich simoni
Biotech, Synthetic Biology, Bicycles, Medical Bioinformatics, Genomics, Genetic Testing, Biotechnology, DNA/RNA, Microbiome, Quantified Self, Medical Devices, Internet of Things, Pharmaceuticals, Bio-Pharma